Inhibition of Neurotoxic Secretory Phospholipases A<sub>2</sub> Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from <i>Harpalyce brasiliana</i> Benth

<table>Trend between docking scores performed by GOLD 4.0 (<i>in silico</i>) and percentages of inhibition of the enzymatic activity (<i>in vitro</i>). The values near the points represent the percentage of inhibition for each PLA2, with the respective PDB ID below. The PDB ID: 1GMZ, 2QOG, 1PSH, and 1POC were used, respectively, for PrTX-III, Cdt F15, Naja, and Apis.</table>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Inhibition of Neurotoxic Secretory Phospholipases A<sub>2</sub> Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from <i>Harpalyce brasiliana</i> Benth 

Figure 5 | Inhibition of Neurotoxic Secretory Phospholipases A2 Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from Harpalyce brasiliana Benth 